Irinotecan Hydrochloride Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Feb 24, 2026 · last update Feb 24, 2026
Manufacturers: Ingenus Pharmaceuticals LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Feb 24, 2026 Updated Feb 24, 2026 Discontinued Feb 24, 2026 |
| Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05) | Ingenus Pharmaceuticals LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Feb 24, 2026 Updated Feb 24, 2026 Discontinued Feb 24, 2026 |